Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

How to Apply for the KRM Ayurveda Limited IPO: Step-by-Step Investment Guide

 

KRM Ayurveda Ltd. operates in the AYUSH healthcare segment through a network of hospitals, clinics, teleconsultation services, and the manufacture of Ayurvedic and herbal products. Incorporated in 2019, the company began with a focus on kidney-related treatments and has since expanded its scope to cover other health conditions, including lifestyle and chronic disorders. Its operations span physical healthcare facilities as well as remote consultation and product distribution channels. The company’s activities are centred on integrating traditional Ayurvedic practices with structured treatment processes. 

Investors who wish to apply for the KRM Ayurveda IPO can do so through the application process prescribed for public issues in India. Applications may be submitted using the ASBA facility through a bank account linked to a demat account, either via net banking or through a registered intermediary. Eligible investors can also apply through online investment platforms that support IPO applications. Applicants are required to select the relevant category, enter the bid details as per the issue terms, and confirm the mandate for blocking funds. Once submitted, the application remains subject to allotment as per regulatory procedures and disclosed timelines.

For more details, visit the KRM Ayurveda Limited IPO page.

KRM Ayurveda Limited IPO Details and Objectives

Details

Information

IPO Date

January 19, 2026 to January 21, 2026

Issue Size

57,40,000 shares (agg. up to ₹77 Cr)

Price Band

₹128 to ₹135 per share

Lot Size

1000 shares

Listing At

NSE, SME

Purpose of the IPO

  • Capital Expenditure for Construction and Development of Telemedicine Operational Facilities

  • Purchase of CRM Software and Hardware Infrastructure

  • Human Resources

  • Repayment/Prepayment of loan

  • To meet the Working Capital requirements of the Company

  • General Corporate Purposes

Timeline of KRM Ayurveda Limited IPO

Event

Date

IPO Open Date

Mon, Jan 19, 2026

IPO Close Date

Wed, Jan 21, 2026

Tentative Allotment

Thu, Jan 22, 2026

Initiation of Refunds

Fri, Jan 23, 2026

Credit of Shares to Demat

Fri, Jan 23, 2026

Tentative Listing Date

Tue, Jan 27, 2026

Cut-off time for UPI mandate confirmation

5 PM on Wed, Jan 21, 2026

Pricing & Lot Size of KRM Ayurveda Limited IPO

Price Band for the IPO

  •  ₹128 to ₹135 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Individual investors (Retail) (Min)

2

2,000

₹2,70,000

Individual investors (Retail) (Max)

2

2,000

₹2,70,000

S-HNI (Min)

3

3,000

₹4,05,000

S-HNI (Max)

7

7,000

₹9,45,000

B-HNI (Min)

8

8,000

₹10,80,000

KRM Ayurveda Limited IPO Application Process

The KRM Ayurveda Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:

Step 1: Login to Your Trading Platform

Access your trading account using the broker's app or website.

Step 2: Navigate to the IPO Section

Go to the IPO section to view active IPO listings.

Step 3: Select the Open IPO and Click Apply

Locate KRM Ayurveda Limited IPO in the list of available IPOs and click the ‘Apply’ button.

Step 4: Enter the Quantity of Shares You Wish to Apply For

Specify the number of shares (lot size: 1000 shares) within the price band of ₹128 to ₹135 per share.

Step 5: Provide Your UPI ID

Enter your UPI ID for payment authorisation and ensure sufficient funds in your bank account.

Step 6: Confirm the Application

Review your application details and confirm the UPI mandate before 5 PM on the last application day.

Step 7: Complete the Process and Wait for Allotment

Submit the application and monitor the allotment status to check if shares have been allocated to you.

Shares Offered in KRM Ayurveda IPO

The allocation of shares in the KRM Ayurveda IPO is structured across investor categories in line with applicable regulatory requirements. The issue provides defined reservations for qualified institutional buyers, non-institutional investors, and retail individual investors, with each category allotted a specified proportion of the net issue. This allocation framework outlines how the shares offered are distributed among different classes of investors.

Investor Category

Shares Offered

QIB Shares Offered

Not more than 50% of the Net Issue

Retail Shares Offered

Not less than 35% of the Net Issue

NII Shares Offered

Not less than 15% of the Net Issue

This reservation structure reflects the categorisation and allocation approach disclosed for the issue, indicating the proportion of shares available to each investor segment.

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹39.48 crore in FY23 to ₹66.79 crore as of March 2025.

  • Total income: Stood at ₹76.95 crore in FY25, as compared to ₹89.38 crore in FY23.

  • Profit After Tax (PAT): Stood at ₹12.10 crore for March 2025 as compared to ₹7.60 crore in FY23.

  • Net Worth: Recorded at ₹23.88 crore in FY25 in comparison to ₹8.37 crore in FY23.

  • Reserves and surplus: Stood at ₹23.73 crore in FY25, as compared to ₹8.22 crore in FY23.

  • EBITDA: Stood at ₹19.11 crore in March 2025 in comparison to ₹11.03 crore in FY23.

Recent Performance and Growth Prospects

  • The company’s asset base has expanded over the review period, indicating a broader operational scale and increased balance sheet size.

  • Total income in the most recent period reflects a moderation compared to an earlier year, suggesting changes in revenue composition or business activity levels.

  • Profit after tax has shown an upward movement over time, reflecting an improvement in post-expense earnings during the period under review.

  • Net worth has strengthened compared to earlier years, supported by internal accruals and retained earnings.

  • Reserves and surplus have increased, indicating accumulation of profits within the business rather than distribution.

  • Operating performance, as reflected at the earnings-before-depreciation-and-tax level, has improved over the period, pointing to better operating outcomes.

  • Overall, recent performance reflects a phase of balance sheet expansion alongside changes in income trends, with internal financial strengthening contributing to the company’s current position.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • The company operates in the AYUSH healthcare segment, where demand patterns, regulatory frameworks, and patient preferences may vary across regions, which can influence operational consistency.

  • A portion of the business is dependent on specialised healthcare services and teleconsultation models, where execution challenges, compliance requirements, or operational integration issues may affect outcomes.

Opportunities and Growth Potential

  • KRM Ayurveda Ltd. has an established presence across hospitals, clinics, product manufacturing, and teleconsultation services, which provides multiple channels for service delivery within the traditional healthcare ecosystem.

  • The stated use of IPO proceeds towards infrastructure development, technology systems, human resources, and working capital reflects a focus on strengthening existing operations and supporting organised business expansion.

Key Performance Indicator (KPI)

KPI

Mar 31, 2025

ROE

67.86%

ROCE

43.33%

Debt/Equity

1.31

RoNW

67.86%

PAT Margin

15.80%

EBITDA Margin

24.96%

Price to Book Value

0.08

KRM Ayurveda Limited IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

Skyline Financial Services Pvt.Ltd.

NEXGEN Financial Solutions Pvt. Ltd.

Company Address of KRM Ayurveda Limited

KRM Ayurveda Ltd. A-16 G T Karnal road North West Delhi, New Delhi, 110033

Phone: +91- 9289101700

Email: compliance@krmayurveda.com

Website: http://www.krmayurvedaindia.com/

Conclusion

KRM Ayurveda Ltd. operates in the AYUSH healthcare segment through hospitals, clinics, teleconsultation services, and Ayurvedic product manufacturing. Since its incorporation in 2019, the company has expanded its treatment scope beyond kidney-related care to include other chronic and lifestyle-related health conditions, supported by physical facilities and remote service channels.

The IPO outlines the company’s business profile, issue structure, objectives, and application process in line with regulatory disclosures. Investors may apply through ASBA-enabled bank accounts or eligible online platforms, subject to the prescribed procedures and timelines. All applications remain subject to allotment as per applicable regulations and issue terms.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your KRM Ayurveda IPO allotment status.   

Frequently Asked Questions

No result found

search icon

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

11 lakh+ Users

icon-with-text

4.8 App Rating

icon-with-text

4 Languages

icon-with-text

₹7,900+ Cr MTF Book

icon-with-text
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|